drugset / Trial / NCT04432428

Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty

NCT04432428

Phase 4 Completed 90 enrolled University Hospital, Ghent
NaSingle-groupOpen-labelTreatment

Summary

The sufentanil sublingual tablet system (SSTS) is an innovative patient-controlled analgesia (PCA) device for the management of acute moderate to severe postoperative pain in hospital settings in adult patients. The SSTS is non-invasive and imposes no restrictions on patient mobility, which renders it particularly suitable for clinical conditions where early mobilization is a key component of successful surgical outcome. The present study tests the hypothesis that SSTS is an efficient and safe analgesic technique allowing fast track rehabilitation after total knee arthroplasty in a prospective cohort design.

Timeline

Start
2020-05-26
Primary completion
2021-08-31
Completion
2021-09-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified 15 ug Other

Indications

No indication recorded.